News & Events

Octapharma USA Sponsored Bombardier Blood Presented by Denver Mountain Climber During Special Hometown Screening

Documentary Features Chris Bombardier’s Quest to Climb the Seven Summits First Denver Screening Hosted by Colorado Chapter of National Hemophilia Foundation

Octapharma USA To Present First Community Screening of Bombardier Blood

Screening Exclusively Open to NHF Annual Meeting Attendees Documentary Features First Hemophiliac to Climb the Seven Summits

Octapharma USA Partners with GutMonkey To Provide Hemophilia Patients Life-Changing Adventure Experience

Leading X San Juan Islands Aims to Enhance Patient Self-Efficacy & Bleeding Disorder Management

Octapharma USA Funds Only National Camp Exchange Program for Bleeding Disorders Community Camps

Interested Camp Professionals Should Apply by May 30th for Grant Funded Program

Chris Bombardier, First Hemophiliac to Climb the Seven Summits, Joins Octapharma USA at HFA Annual Symposium in Cleveland

Mountain Climber Will Discuss Mount Everest Climb, Upcoming Documentary One-on-One With Visitors of Octapharma Booth

Octapharma Support Enables Bombardier to Climb Mount Vinson, Becoming First Hemophiliac to Ascend the Seven Summits

Octapharma Partnership with Mountain Climber will Culminate with Release of Documentary Bombardier Blood Later This Year

Octapharma USA Grant Supports Mission of First Hemophiliac to Climb the Seven Summits of the World

Octapharma Partnership with Mountain Climber will Culminate with Climb of Mount Vinson & Release of Documentary

Octapharma USA Sponsors NHF Annual Meeting, Shares Inspirational Bleeding Disorders Community Achievements

HOBOKEN, N.J. (August 29, 2017) – Octapharma USA sponsored the National Hemophilia Foundation’s 69th Annual Meeting in Chicago and provided a patient symposium sharing the inspirational stories of three young men with bleeding disorders, including Chris Bombardier, who recently became …
More

Octapharma USA Announces FDA Approval of NUWIQ® New Product Strengths, Expanding Hemophilia A Patient Treatment Options

New Higher Vial Strengths will Provide Added Dosing Flexibility & Convenience HOBOKEN, N.J. (August 22, 2017) – Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved new product strengths for NUWIQ®, offering added convenience by potentially …
More

Octapharma USA Grant Funds First National Camp Exchange Program for Bleeding Disorders Community Camps

HOBOKEN, N.J. (July 13, 2017) – Octapharma USA has provided a grant to fund the first National Camp Exchange (NCE) for the bleeding disorders community, an adjunct program of the North American Camping Conference of Hemophilia Organizations (NACCHO). NCE will …
More